Growth Metrics

SELLAS Life Sciences Group (SLS) Change in Account Payables: 2010-2024

Historic Change in Account Payables for SELLAS Life Sciences Group (SLS) over the last 15 years, with Dec 2024 value amounting to -$2.1 million.

  • SELLAS Life Sciences Group's Change in Account Payables fell 391.75% to -$1.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $297,000, marking a year-over-year decrease of 86.58%. This contributed to the annual value of -$2.1 million for FY2024, which is 192.96% down from last year.
  • Per SELLAS Life Sciences Group's latest filing, its Change in Account Payables stood at -$2.1 million for FY2024, which was down 192.96% from $2.3 million recorded in FY2023.
  • In the past 5 years, SELLAS Life Sciences Group's Change in Account Payables registered a high of $2.3 million during FY2023, and its lowest value of -$2.5 million during FY2021.
  • For the 3-year period, SELLAS Life Sciences Group's Change in Account Payables averaged around $458,333, with its median value being $1.2 million (2022).
  • Per our database at Business Quant, SELLAS Life Sciences Group's Change in Account Payables slumped by 7,066.67% in 2020 and then surged by 148.27% in 2022.
  • Over the past 5 years, SELLAS Life Sciences Group's Change in Account Payables (Yearly) stood at -$836,000 in 2020, then crashed by 200.60% to -$2.5 million in 2021, then spiked by 148.27% to $1.2 million in 2022, then skyrocketed by 89.69% to $2.3 million in 2023, then tumbled by 192.96% to -$2.1 million in 2024.